my email rec'd @ 8:16AM Innovation Pharmaceuticals

New Post Public Reply Private Reply Replies (1) Message Board
4kids 4kids #53976
494
my email rec'd @ 8:16AM


Innovation Pharmaceuticals Requesting European Medicines Agency (EMA) Input for International Phase 3 Brilacidin Oral Mucositis Program
Fri, Mar 15, 2019 8:16 am

currently NR has had 60000 in volume go off hidden (as of 10:03:39AM listed
edited in follow on trades)
60000/102850 = 58.33%

not a % i'd expect to see if NR had access to *liquidity*
to say nothing of how the IPIX *trades* have had to be marked since 3.1.19

Mar 14 NA NA NA 264,241 210,400 79.62%
Mar 13 NA NA NA 384,406 295,944 76.99%
Mar 12 NA NA NA 278,799 227,807 81.71%
Mar 11 NA NA NA 359,435 254,248 70.74%
Mar 08 NA NA NA 219,203 146,016 66.61%
Mar 07 NA NA NA 226,552 213,443 94.21%
Mar 06 NA NA NA 466,807 368,784 79.00%
Mar 05 NA NA NA 371,973 258,296 69.44%
Mar 04 NA NA NA 475,644 301,557 63.40%
Mar 01 NA NA NA 355,785 301,825 84.83%


of course it is early in the day .. but again watching to see what *volume*
can be engendered today .. how it is *marked* and COM hidden % info

trades


10:31:00 0.127 2000 OTO

10:28:30 0.13 472 OTO
10:23:11 0.1325 19528 OTO
10:23:11 0.1325 472 OTO
10:23:00 0.1413 10000 OTO
10:22:01 0.1388 2500 OTO
10:20:47 0.127 1300 OTO
10:20:47 0.13 1200 OTO
10:20:47 0.1325 2500 OTO
10:20:47 0.1325 30000 OTO

10:16:51 0.131 5000 OTO
10:15:45 0.13 5000 OTO
10:11:56 0.13 600 OTO

10:03:39 0.127 10000 OTO
10:02:32 0.124 5000 OTO
10:02:24 0.1212 10000 OTO
09:43:51 0.122 5000 OTO
09:43:51 0.124 10000 OTO
09:43:50 0.126 5000 OTO
09:33:39 0.123 10000 OTO
09:33:31 0.12 2000 OTO
09:33:25 0.12 3000 OTO
09:32:21 0.1144 10000 OTO
09:31:58 0.1137 7500 OTO
09:31:58 0.1145 2500 OTO
09:31:07 0.12 1850 OTO
09:30:55 0.125 4883 OTO
09:30:40 0.126 5000 OTO
09:30:31 0.126 10000 OTO
09:30:03 0.126 117 OTO
09:30:01 0.13 1000 OTO



Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.127Up 0.0081 (6.81 %)AS OF 10:03:39AM ET 03/15/2019

Last Trade 0.127
Trade Time 10:03:39am ET

Change 0.0081
% Change 6.81%

Bid 0.12
Bid Size 21150

Ask 0.13
Ask Size 5000


Open 0.13
Day High 0.13
Day Low 0.1137
Previous Close
03/14/2019 0.1189
52-Week High
05/16/2018 0.69475
52-Week Low
12/31/2018 0.07

Price Performance (Last 52 Weeks)
03/14/2019 -80.18%

Volume 102,850
Volume (10 day Average) 340,285
Volume (90 day Average) 531,649

Market Capitalization $21.35M
Shares Outstanding 179,573,000



B/A .. volume 102850

CANT 0.12 21,150 09:35
ETRF 0.117 25,000 09:59
CDEL 0.115 6,255 10:02
NITE 0.111 5,000 09:43
CSTI 0.11 5,507 09:30

CSTI 0.13 5,000 08:30
ETRF 0.1325 30,000 09:33
CDEL 0.145 10,000 10:02
PAUL 0.15 5,000 09:20
VERT 0.20 2,500 02/05


edited in ..

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.1325Up 0.0136 (11.44 %)AS OF 10:23:11AM ET 03/15/2019

Last Trade 0.1325
Trade Time 10:23:11am ET

Change 0.0136
% Change 11.44%

Bid 0.127
Bid Size 8700

Ask 0.14
Ask Size 5000

Open 0.13
Day High 0.14125
Day Low 0.1137
Previous Close
03/14/2019 0.1189
52-Week High
05/16/2018 0.69475
52-Week Low
12/31/2018 0.07

Price Performance (Last 52 Weeks)
03/14/2019 -80.18%

Volume 180,950
Volume (10 day Average) 340,285
Volume (90 day Average) 531,649

Market Capitalization $21.35M
Shares Outstanding 179,573,000



ETRF 0.127 8,700 10:23
CANT 0.12 21,150 09:35
CDEL 0.115 6,255 10:23
NITE 0.111 5,000 09:43
CSTI 0.11 5,507 09:30

ETRF 0.1358 14,880 10:26
CDEL 0.14 5,000 10:23
CSTI 0.145 5,000 10:15
PAUL 0.15 5,000 09:20
VERT 0.20 2,500 02/05


edited in ..

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.13Up 0.0111 (9.34 %)AS OF 10:28:30AM ET 03/15/2019

Last Trade 0.13
Trade Time 10:28:30am ET

Change 0.0111
% Change 9.34%

Bid 0.127
Bid Size 8700

Ask 0.13
Ask Size 5000

Open 0.13
Day High 0.14125
Day Low 0.1137
Previous Close
03/14/2019 0.1189
52-Week High
05/16/2018 0.69475
52-Week Low
12/31/2018 0.07

Price Performance (Last 52 Weeks)
03/14/2019 -80.18%

Volume 181,422
Volume (10 day Average) 340,285
Volume (90 day Average) 531,649

Market Capitalization $21.35M
Shares Outstanding 179,573,000



ETRF 0.127 8,700 10:23
CANT 0.12 21,150 09:35
CDEL 0.112 15,258 10:28
NITE 0.111 5,000 09:43
CSTI 0.11 5,507 09:30

CDEL 0.13 5,000 10:28
NITE 0.135 50,000 10:27
ETRF 0.1358 14,880 10:26
PAUL 0.14 5,000 10:27
CSTI 0.145 5,000 10:15


edited in ..

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.127Up 0.0081 (6.81 %)AS OF 10:31:00AM ET 03/15/2019

Last Trade 0.127
Trade Time 10:31:00am ET

Change 0.0081
% Change 6.81%

Bid 0.127
Bid Size 8700

Ask 0.13
Ask Size 5000

Open 0.13
Day High 0.14125
Day Low 0.1137
Previous Close
03/14/2019 0.1189
52-Week High
05/16/2018 0.69475
52-Week Low
12/31/2018 0.07

Price Performance (Last 52 Weeks)
03/14/2019 -80.18%

Volume 183,422
Volume (10 day Average) 340,285
Volume (90 day Average) 531,649

Market Capitalization $21.35M
Shares Outstanding 179,573,000


ETRF 0.127 8,700 10:23
CANT 0.12 21,150 09:35
CDEL 0.112 15,258 10:28
NITE 0.111 5,000 09:43
CSTI 0.11 5,507 09:30

CDEL 0.13 5,000 10:28
NITE 0.135 50,000 10:27
ETRF 0.1358 14,880 10:26
PAUL 0.14 5,000 10:27
CSTI 0.145 5,000 10:15




will update ..

4kids

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Updated Category News Views 13

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 16

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 7

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 9

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Skandia's Soundproofing Kit Expands to Brazil's Skies

Updated Category News Views 7

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 17

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day

Updated Category News Views 11

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Continue Reading
Navigating Holiday Sweets: Healthy Balancing Acts

Updated Category News Views 11

In the middle of the sweet madness that is the holiday season, Crispy Green and Dr. Nicole Avena are playing guide to families drowning in sugar. This isn't just a once-a-year Halloween headache; we're starting that sugar spiral early and letting it ride until the New Year approaches. It's an all-hands-on-deck situation if families want to dodge that sugar overload. Why...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 13

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 10

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading

Top 5 Most Recently Viewed Articles

Adagene Provides Insights on Phase 2 Clinical Trial Plans

Updated Category News Views 137

Adagene's Clinical Development Plan for Muzastotug Adagene Inc. (NASDAQ: ADAG), a forward-thinking company dedicated to innovating antibody-based therapies, has some exciting news to share regarding its ongoing clinical efforts. After a constructive Type B meeting with the FDA, Adagene is gearing up to move forward with its clinical development plan for muzastotug...

Continue Reading
ProVen VCT plc Shares: Total Voting Rights Announcement

Updated Category News Views 131

ProVen VCT plc Shares Summary ProVen VCT plc Total Voting Rights Announcement Under the Disclosure and Transparency Rule 5.6.1, ProVen VCT plc has disclosed important information regarding its share capital and voting rights, effective as of the end of May 2025. Details of Shares and Voting Rights As of May 31, 2025, ProVen VCT plc has outlined the following details...

Continue Reading
Celebrate Your Pets at the Tractor Supply Event This Year

Updated Category News Views 648

Tractor Supply Company Kicks Off Pet Appreciation Days Tractor Supply Company (NASDAQ: TSCO), known as the leading rural lifestyle retailer in the United States, is eager to announce the commencement of its annual Pet Appreciation Days. This event celebrates the bond between pets and their owners and provides an opportunity to enjoy exclusive deals on various pet-related...

Continue Reading
Growth Projections in the Global Acoustic Ceiling Tiles Market

Updated Category News Views 144

Overview of Acoustic Ceiling Tiles Market Custom Market Insights has recently released a comprehensive report on the global Acoustic Ceiling Tiles market. This report highlights the burgeoning demand for acoustic ceiling tiles and predicts a market worth approximately USD 11.53 billion by 2033, growing at a striking compound annual growth rate (CAGR) of 5.21% from 2024 to...

Continue Reading
Legal Investigation for Long-Term Shareholders of Major Companies

Updated Category News Views 150

Investigation of Amylyx Pharmaceuticals, Inc. Grabar Law Office is actively looking into claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX). Recent developments indicate that allegations of securities fraud in a class action have persisted against the company, successfully overcoming a motion to dismiss. What You Need to Know If you acquired...

Continue Reading